Primavera Venture Partners
Overview
Primavera Venture Partners is the venture capital arm of Primavera Capital Group. It invests across Pre-Seed, Seed, Series A, and B rounds. The firm proactively invests in sectors including Artificial Intelligence (AI), Biotech & Medicine, and Climate Action. The parent company, Primavera Capital Group, is a China-based global investment firm founded in 2010 that invests in private equity and special situations across Asia.
Portfolio Companies
4
Website
pvp.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hex Trust | Mar 2022 | Series B | Co-investor |
| Blackpanda | Jan 2023 | Series A | Lead |
| Starna Therapeutics | May 2022 | Series A | Co-investor |
| Subtle Medical | Nov 2022 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Primavera Venture Partners based?
Primavera Venture Partners is headquartered in Beijing, Beijing, China.
When was Primavera Venture Partners founded?
Founding year information for Primavera Venture Partners is not publicly available.
How many portfolio companies does Primavera Venture Partners have?
Primavera Venture Partners has 4 portfolio companies in Caplight's dataset.
What are some companies in Primavera Venture Partners's portfolio?
Portfolio companies visible on Caplight include Hex Trust, Blackpanda, Starna Therapeutics, Subtle Medical.
What was Primavera Venture Partners's most recent investment shown here?
Primavera Venture Partners's most recent investment in this portfolio sample was in Blackpanda in 2023.
What sectors does Primavera Venture Partners focus on?
Primavera Venture Partners focuses on Healthcare & Life Sciences, Cybersecurity, Healthcare & Life Sciences, Crypto & Web3, FinTech, AI, Data & Cloud Infrastructure, FinTech.
What company stages does Primavera Venture Partners focus on?
Primavera Venture Partners typically invests at the Early stage.
What is Primavera Venture Partners's AUM?
Primavera Venture Partners's assets under management are estimated between $500.0M and $500.0M.